STOCK TITAN

QUANTUM GENESIS Financials

QGAI
Source SEC Filings (10-K/10-Q) Updated Mar 19, 2026 Currency USD FYE July

This page shows QUANTUM GENESIS (QGAI) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Piotroski F-Score Weak
1/9

QUANTUM GENESIS passes 1 of 9 financial strength tests. 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), neither operating efficiency signal passes.

Earnings Quality Low Quality
0.63x

For every $1 of reported earnings, QUANTUM GENESIS generates $0.63 in operating cash flow (-$125K OCF vs -$199K net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Interest Coverage At Risk
-8.5x

QUANTUM GENESIS earns $-8.5 in operating income for every $1 of interest expense (-$181K vs $21K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$0

QUANTUM GENESIS generated $0 in revenue in fiscal year 2025.

EBITDA
N/A
Net Income
-$199K
YoY-11.6%

QUANTUM GENESIS reported -$199K in net income in fiscal year 2025. This represents a decrease of 11.6% from the prior year.

EPS (Diluted)
$-0.01
YoY+0.0%

QUANTUM GENESIS earned $-0.01 per diluted share (EPS) in fiscal year 2025. This represents an increase of 0.0% from the prior year.

Cash & Balance Sheet

Free Cash Flow
N/A
Cash & Debt
$184
YoY-96.4%

QUANTUM GENESIS held $184 in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share
N/A
Shares Outstanding
39M
YoY+12.0%

QUANTUM GENESIS had 39M shares outstanding in fiscal year 2025. This represents an increase of 12.0% from the prior year.

Margins & Returns

Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
Return on Equity
N/A

Capital Allocation

R&D Spending
N/A
Share Buybacks
N/A
Capital Expenditures
N/A

QGAI Income Statement

Metric Q3'26 Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24
Revenue N/A $0 N/A $0 N/A $0 N/A $0
Cost of Revenue N/A N/A N/A N/A N/A N/A N/A N/A
Gross Profit N/A N/A N/A N/A N/A N/A N/A N/A
R&D Expenses N/A N/A N/A N/A N/A N/A N/A N/A
SG&A Expenses $19K+20.6% $16K N/A $11K N/A $2K N/A $8K
Operating Income -$1K+96.5% -$39K N/A N/A N/A -$61K N/A N/A
Interest Expense $13K+22.5% $11K N/A $5K N/A $5K N/A $4K
Income Tax N/A $0 N/A $0 N/A $0 N/A $0
Net Income -$4.3M-8582.2% -$50K N/A -$66K-120.6% -$30K+54.5% -$66K N/A -$64K
EPS (Diluted) $-0.12 $0.00 N/A N/A N/A $0.00 N/A N/A

QGAI Balance Sheet

Metric Q3'26 Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24
Total Assets N/A $184-68.5% $5840.0% $584 N/A N/A $10K N/A
Current Assets N/A $184-68.5% $5840.0% $584 N/A N/A $10K N/A
Cash & Equivalents N/A $184-68.5% $5840.0% $584 N/A $5K $0 $0
Inventory N/A N/A N/A N/A N/A N/A N/A N/A
Accounts Receivable N/A N/A N/A N/A N/A N/A N/A N/A
Goodwill N/A N/A N/A N/A N/A N/A N/A N/A
Total Liabilities N/A $491K+11.2% $441K+9.5% $403K N/A N/A $451K N/A
Current Liabilities N/A $491K+11.2% $441K+9.5% $403K N/A N/A $293K N/A
Long-Term Debt N/A N/A N/A N/A N/A N/A N/A N/A
Total Equity N/A -$491K-11.3% -$441K-9.5% -$403K-7.9% -$373K+25.5% -$501K-13.6% -$441K-109.2% $4.8M
Retained Earnings N/A -$5.7M-0.9% -$5.6M-0.7% -$5.6M N/A N/A -$5.4M N/A

QGAI Cash Flow Statement

Metric Q3'26 Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24
Operating Cash Flow -$24K-20.0% -$20K-130.7% -$9K N/A N/A -$35K-160.6% -$13K N/A
Capital Expenditures N/A N/A N/A N/A N/A N/A N/A N/A
Free Cash Flow N/A N/A N/A N/A N/A N/A N/A N/A
Investing Cash Flow N/A N/A N/A N/A N/A N/A N/A N/A
Financing Cash Flow $24K+21.8% $20K+126.1% $9K N/A N/A $40K+198.3% $13K N/A
Dividends Paid N/A N/A N/A N/A N/A N/A N/A N/A
Share Buybacks N/A N/A N/A N/A N/A N/A N/A N/A

QGAI Financial Ratios

Metric Q3'26 Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24
Gross Margin N/A N/A N/A N/A N/A N/A N/A N/A
Operating Margin N/A N/A N/A N/A N/A N/A N/A N/A
Net Margin N/A N/A N/A N/A N/A N/A N/A N/A
Return on Equity N/A N/A N/A N/A N/A N/A N/A -1.3%
Return on Assets N/A -27102.2% N/A -11260.8% N/A N/A N/A N/A
Current Ratio N/A 0.000.0 0.000.0 0.00 N/A N/A 0.03 N/A
Debt-to-Equity N/A -1.000.0 -1.000.0 -1.00 N/A N/A -1.02 N/A
FCF Margin N/A N/A N/A N/A N/A N/A N/A N/A

Note: Shareholder equity is negative (-$491K), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.00), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Frequently Asked Questions

QUANTUM GENESIS (QGAI) reported $0 in total revenue for fiscal year 2025. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

No, QUANTUM GENESIS (QGAI) reported a net income of -$199K in fiscal year 2025.

QUANTUM GENESIS (QGAI) reported diluted earnings per share of $-0.01 for fiscal year 2025. This represents a 0.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

QUANTUM GENESIS (QGAI) generated -$125K in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

QUANTUM GENESIS (QGAI) had $184 in total assets as of fiscal year 2025, including both current and long-term assets.

QUANTUM GENESIS (QGAI) had 39M shares outstanding as of fiscal year 2025.

QUANTUM GENESIS (QGAI) had a current ratio of 0.00 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

QUANTUM GENESIS (QGAI) had a debt-to-equity ratio of -1.00 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

QUANTUM GENESIS (QGAI) had a return on assets of -108298.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Based on fiscal year 2025 data, QUANTUM GENESIS (QGAI) had $184 in cash against an annual operating cash burn of $125K. This gives an estimated cash runway of approximately 0 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

QUANTUM GENESIS (QGAI) has negative shareholder equity of -$491K as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

QUANTUM GENESIS (QGAI) has a Piotroski F-Score of 1 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

QUANTUM GENESIS (QGAI) has an earnings quality ratio of 0.63x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

QUANTUM GENESIS (QGAI) has an interest coverage ratio of -8.5x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Back to top